EATG » Access

Access

Policy makers’ inaction is leading people to take PrEP ‘in the wild’

An increasing number of gay men and others at risk of HIV are seeking to protect their health with PrEP (pre-exposure prophylaxis), but the lack of PrEP provision and lack…

ECDC: Pre-exposure prophylaxis for HIV prevention in Europe – the status quo

Pre-exposure prophylaxis (PrEP) is the use of an antiretroviral medication by people who are HIV-negative with the aim to prevent HIV infection. So far, France is the only country in…

People with hepatitis C in Canada have limited access to direct-acting antivirals

More than 85 % of Canadian provinces and territories restrict access to new direct-acting antivirals (DAA) for the treatment of the hepatitis C. A pill a day for 12 weeks.…

The Hepatitis C Trust ends its legal challenge

The court has refused permission for the judicial review the Hepatitis C Trust has sought on NHS England’s decision to restrict access to hepatitis C treatment to be heard. The…

PrEP in Europe Initiative

The PrEP in Europe Initiative (PiEi) is a new initiative, a coalition of European organisations and activists concerned with HIV prevention and specifically with ensuring access to PrEP (pre-exposure prophylaxis)…

EU Committee pressures Commission to create Europe-wide drug pricing initiatives

The European Parliament Committee on the Environment, Public Health and Food Safety (ENVI) has called for continent-wide initiatives to improve access to medicines. In a draft report, ENVI takes the…

HIV i-Base: September/October 2016 issue of HIV Treatment Bulletin now online

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base every two months. HTB reviews the most important advances in the clinical management of HIV and access to…

European regulator limits some Gilead hep C patent claims

In a setback for Gilead Sciences, European regulators decided not to uphold all of its patent claims for the best-selling Sovaldi hepatitis C treatment, a move that could lead to…

Medicines Patent Pool announces MedsPaL: its new Medicines Patents & Licences Database

MPP’s signature database upgraded to include patent and licensing data for HIV, hepatitis C and TB medicines Geneva, 5 October 2016 – The Medicines Patent Pool today announced the launch…

UNITAID and FIND launch initiative to improve diagnostics and treatment for hepatitis C

GENEVA, 4 October 2016 - UNITAID today announced a partnership with FIND to improve diagnostics and treatments for hepatitis C virus (HCV) and make them more affordable and widely available to…